- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, April 24, 2020
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A piece by HealthTech Magazine titled “What Does the Future Hold for Telehealth?” referenced a commentary published in the April 2020 issue of The American Journal of Managed Care® (AJMC®). In the article, “Incorporating Telemedicine as Part of COVID-19 Outbreak Response Systems,” 2 attorneys from the international firm Jones Day highlighted that healthcare providers should revisit disaster response policies to incorporate telemedicine systems to address some of the unique challenges posed by infectious disease outbreaks such as coronavirus disease 2019.
An article by HIT Consultant cited a contributor article published on AJMC.com, the website of AJMC®. The article, “The ROI of Addressing Social Determinants of Health,” found that by using a novel return-on-investment model and calculator, healthcare professionals can illustrate the financial impact of investing in a software tailored to address social determinants of health, which can lead to reductions in readmissions from leading medical conditions and, ultimately, cost savings for the hospital.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Targeted Treatment May Improve Outcomes in IDH1-Mutated MDS
January 13th 2025A pair of abstracts presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exhibition suggest that IDH1-targeted treatment may improve survival among patients with myelodysplastic syndromes (MDS) with the mutation.
Read More
